Profil
Ole Kristian Hjelstuen currently works at Inven2 AS, as CEO, Legal & Communication from 2012.
Dr. Hjelstuen also formerly worked at Ultimovacs ASA, as Director.
Dr. Hjelstuen received his doctorate degree in 1999 from the University of Oslo.
Postes actifs de Ole Kristian Hjelstuen
| Sociétés | Poste | Début |
|---|---|---|
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 invests in technology based companies located in Norway. The firm targets companies operating in the fields of a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Directeur Général | 01/04/2012 |
Anciens postes connus de Ole Kristian Hjelstuen
| Sociétés | Poste | Fin |
|---|---|---|
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Directeur/Membre du Conseil | - |
Formation de Ole Kristian Hjelstuen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 invests in technology based companies located in Norway. The firm targets companies operating in the fields of a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
















